Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy
To investigate the potential clinical value of urinary exosomal (uE) miR-451a as a biomarker for IgAN, urinary exosomes were isolated from 40 patients with IgAN, 30 patients with primary renal diseases without IgA as disease controls (non-IgAN group) and 21 healthy controls (HCs). The expression of...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Renal Failure |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2024.2319326 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832591109386141696 |
---|---|
author | Qiong Zhang Yan Zhao Yankun Luo Songjia Guo Haizhu Hou Xiaoli Han Yun Zhou |
author_facet | Qiong Zhang Yan Zhao Yankun Luo Songjia Guo Haizhu Hou Xiaoli Han Yun Zhou |
author_sort | Qiong Zhang |
collection | DOAJ |
description | To investigate the potential clinical value of urinary exosomal (uE) miR-451a as a biomarker for IgAN, urinary exosomes were isolated from 40 patients with IgAN, 30 patients with primary renal diseases without IgA as disease controls (non-IgAN group) and 21 healthy controls (HCs). The expression of miR-451a within exosomes was examined by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). uE miR-451a was significantly upregulated in patients with IgAN compared to non-IgAN and HCs. The uE miR-451a level was positively correlated with the change in eGFR and negatively correlated with serum creatinine, urinary macrophage migration inhibitory factor (MIF), interleukin-6 (IL-6) and tumor necrosis factor (TNF-α). A dual-luciferase reporter assay confirmed that MIF was a direct target of miR-451a. Receiver operating characteristic (ROC) curve analysis revealed that the expression of uE miR-451a showed potential diagnostic value for IgAN. Additionally, the uE miR-451a level could distinguish patients with IgAN with mild tubular atrophy/interstitial fibrosis from those with severe tubular atrophy/interstitial fibrosis. After a mean follow-up of 14.2 months, the levels of eGFR loss (ml/min/1.73 m2/year) were negatively correlated with baseline miR-451a. The levels of baseline miR-451a in the complete remission group were significantly higher than those in the non-complete remission group. uE miR-451a expression was significantly elevated in patients with IgA nephropathy and may serve as a potential biomarker for the diagnosis of IgAN and evaluation of tubulointerstitial damage, while the baseline levels of uE miR-451a may be predictors of therapeutic efficacy and disease progression. |
format | Article |
id | doaj-art-85ce6f88aef842d0985c994b861121a8 |
institution | Kabale University |
issn | 0886-022X 1525-6049 |
language | English |
publishDate | 2024-12-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | Renal Failure |
spelling | doaj-art-85ce6f88aef842d0985c994b861121a82025-01-23T04:17:47ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492024-12-0146110.1080/0886022X.2024.2319326Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathyQiong Zhang0Yan Zhao1Yankun Luo2Songjia Guo3Haizhu Hou4Xiaoli Han5Yun Zhou6Department of Nephrology, The Fifth Clinical Medical College of Shanxi Medical University, Fifth Hospital of Shanxi Medical University, Taiyuan, ChinaDepartment of Nephrology, The Fifth Clinical Medical College of Shanxi Medical University, Fifth Hospital of Shanxi Medical University, Taiyuan, ChinaDepartment of Nephrology, The Fifth Clinical Medical College of Shanxi Medical University, Fifth Hospital of Shanxi Medical University, Taiyuan, ChinaDepartment of Nephrology, The Fifth Clinical Medical College of Shanxi Medical University, Fifth Hospital of Shanxi Medical University, Taiyuan, ChinaDepartment of Nephrology, The Fifth Clinical Medical College of Shanxi Medical University, Fifth Hospital of Shanxi Medical University, Taiyuan, ChinaDepartment of Nephrology, The Fifth Clinical Medical College of Shanxi Medical University, Fifth Hospital of Shanxi Medical University, Taiyuan, ChinaDepartment of Nephrology, The Fifth Clinical Medical College of Shanxi Medical University, Fifth Hospital of Shanxi Medical University, Taiyuan, ChinaTo investigate the potential clinical value of urinary exosomal (uE) miR-451a as a biomarker for IgAN, urinary exosomes were isolated from 40 patients with IgAN, 30 patients with primary renal diseases without IgA as disease controls (non-IgAN group) and 21 healthy controls (HCs). The expression of miR-451a within exosomes was examined by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). uE miR-451a was significantly upregulated in patients with IgAN compared to non-IgAN and HCs. The uE miR-451a level was positively correlated with the change in eGFR and negatively correlated with serum creatinine, urinary macrophage migration inhibitory factor (MIF), interleukin-6 (IL-6) and tumor necrosis factor (TNF-α). A dual-luciferase reporter assay confirmed that MIF was a direct target of miR-451a. Receiver operating characteristic (ROC) curve analysis revealed that the expression of uE miR-451a showed potential diagnostic value for IgAN. Additionally, the uE miR-451a level could distinguish patients with IgAN with mild tubular atrophy/interstitial fibrosis from those with severe tubular atrophy/interstitial fibrosis. After a mean follow-up of 14.2 months, the levels of eGFR loss (ml/min/1.73 m2/year) were negatively correlated with baseline miR-451a. The levels of baseline miR-451a in the complete remission group were significantly higher than those in the non-complete remission group. uE miR-451a expression was significantly elevated in patients with IgA nephropathy and may serve as a potential biomarker for the diagnosis of IgAN and evaluation of tubulointerstitial damage, while the baseline levels of uE miR-451a may be predictors of therapeutic efficacy and disease progression.https://www.tandfonline.com/doi/10.1080/0886022X.2024.2319326MicroRNAnoninvasive biomarkersIgA nephropathytubulointerstitial damagetherapeutic response |
spellingShingle | Qiong Zhang Yan Zhao Yankun Luo Songjia Guo Haizhu Hou Xiaoli Han Yun Zhou Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy Renal Failure MicroRNA noninvasive biomarkers IgA nephropathy tubulointerstitial damage therapeutic response |
title | Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy |
title_full | Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy |
title_fullStr | Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy |
title_full_unstemmed | Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy |
title_short | Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy |
title_sort | urinary exosomal mirna 451a can be used as a potential noninvasive biomarker for diagnosis reflecting tubulointerstitial damage and therapeutic response in iga nephropathy |
topic | MicroRNA noninvasive biomarkers IgA nephropathy tubulointerstitial damage therapeutic response |
url | https://www.tandfonline.com/doi/10.1080/0886022X.2024.2319326 |
work_keys_str_mv | AT qiongzhang urinaryexosomalmirna451acanbeusedasapotentialnoninvasivebiomarkerfordiagnosisreflectingtubulointerstitialdamageandtherapeuticresponseiniganephropathy AT yanzhao urinaryexosomalmirna451acanbeusedasapotentialnoninvasivebiomarkerfordiagnosisreflectingtubulointerstitialdamageandtherapeuticresponseiniganephropathy AT yankunluo urinaryexosomalmirna451acanbeusedasapotentialnoninvasivebiomarkerfordiagnosisreflectingtubulointerstitialdamageandtherapeuticresponseiniganephropathy AT songjiaguo urinaryexosomalmirna451acanbeusedasapotentialnoninvasivebiomarkerfordiagnosisreflectingtubulointerstitialdamageandtherapeuticresponseiniganephropathy AT haizhuhou urinaryexosomalmirna451acanbeusedasapotentialnoninvasivebiomarkerfordiagnosisreflectingtubulointerstitialdamageandtherapeuticresponseiniganephropathy AT xiaolihan urinaryexosomalmirna451acanbeusedasapotentialnoninvasivebiomarkerfordiagnosisreflectingtubulointerstitialdamageandtherapeuticresponseiniganephropathy AT yunzhou urinaryexosomalmirna451acanbeusedasapotentialnoninvasivebiomarkerfordiagnosisreflectingtubulointerstitialdamageandtherapeuticresponseiniganephropathy |